The recent development, application, and future prospects of muscle atrophy animal models

Abstract

Muscle atrophy, characterized by the loss of muscle mass and function, is a hallmark of sarcopenia and cachexia, frequently associated with aging, malignant tumors, chronic heart failure, and malnutrition. Moreover, it poses significant challenges to human health, leading to increased frailty, reduced quality of life, and heightened mortality risks. Despite extensive research on sarcopenia and cachexia, consensus in their assessment remains elusive, with inconsistent conclusions regarding their molecular mechanisms. Muscle atrophy models are crucial tools for advancing research in this field. Currently, animal models of muscle atrophy used for clinical and basic scientific studies are induced through various methods, including aging, genetic editing, nutritional modification, exercise, chronic wasting diseases, and drug administration. Muscle atrophy models also include in vitro and small organism models. Despite their value, each of these models has certain limitations. This review focuses on the limitations and diverse applications of muscle atrophy models to understand sarcopenia and cachexia, and encourage their rational use in future research, therefore deepening the understanding of underlying pathophysiological mechanisms, and ultimately advancing the exploration of therapeutic strategies for sarcopenia and cachexia.

Keywords

cachexia / modeling strategies / muscle atrophy / muscle atrophy models / sarcopenia

References

[1] SkouST, MairFS, FortinM, et al. Multimorbidity. Nat Rev Dis Primers. 2022;8(1):48.

[2] BullockAF, Patterson MJ, PatonLW, CurrowDC, Johnson MJ. Malnutrition, sarcopenia and cachexia: exploring prevalence, overlap, and perceptions in older adults with cancer. Eur J Clin Nutr. 2024;78(6):486-493.

[3] Cruz-JentoftAJ, SayerAA. Sarcopenia. Lancet. 2019;393(10191):2636-2646.

[4] YuanS, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533.

[5] NishikawaH, Fukunishi S, AsaiA, YokohamaK, Nishiguchi S, HiguchiK. Pathophysiology and mechanisms of primary sarcopenia (Review). Int J Mol Med. 2021;48(2):156.

[6] SayerAA, Cruz-Jentoft A. Sarcopenia definition, diagnosis and treatment: consensus is growing. Age Ageing. 2022;51(10):afac220.

[7] SavelievaI, Fumagalli S, KennyRA, et al. EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the heart rhythm society (HRS), Asia pacific heart rhythm society (APHRS), latin america heart rhythm society (LAHRS), and cardiac arrhythmia society of Southern Africa (CASSA). Europace: Eur Pacing Arrhythmias Card Electrophysiol: J Work Groups Card Pacing Arrhythmias Card Cell Electrophysiol Eur Soc Cardiol. 2023;25(4):1249-1276.

[8] ArgilésJM, López-Soriano FJ, StemmlerB, BusquetsS. Cancer-associated cachexia—understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol. 2023;20(4):250-264.

[9] SiddiquiJA, Pothuraju R, JainM, BatraSK, NasserMW. Advances in cancer cachexia: intersection between affected organs, mediators, and pharmacological interventions. Biochim Biophys Acta (BBA)—Rev Cancer. 2020;1873(2):188359.

[10] LooijaardSMLM, Te Lintel Hekkert ML, WüstRCI, OttenRHJ, Meskers CGM, MaierAB. Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass. Acta Physiol. 2021;231(1):e13516.

[11] Meza-ValderramaD, Marco E, Dávalos-YeroviV, et al. Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer. Nutrients. 2021;13(3):761.

[12] WiedmerP, JungT, CastroJP, et al. Sarcopenia—molecular mechanisms and open questions. Ageing Res Rev. 2021;65:101200.

[13] KimJW, KimR, ChoiH, Lee SJ, BaeGU. Understanding of sarcopenia: from definition to therapeutic strategies. Arch Pharmacal Res. 2021;44(9-10):876-889.

[14] DowlingP, GarganS, SwandullaD, Ohlendieck K. Fiber-type shifting in sarcopenia of old age: proteomic profiling of the contractile apparatus of skeletal muscles. Int J Mol Sci. 2023;24(3):2415.

[15] MarzettiE, Lozanoska-Ochser B, CalvaniR, LandiF, Coelho-Júnior HJ, PiccaA. Restoring mitochondrial function and muscle satellite cell signaling: remedies against age-related sarcopenia. Biomolecules. 2024;14(4):415.

[16] SetiawanT, SariIN, WijayaYT, et al. Cancer cachexia: molecular mechanisms and treatment strategies. J Hematol Oncol. 2023;16(1):54.

[17] ZarifiSH, Bagherniya M, BanachM, JohnstonTP, Sahebkar A. Phytochemicals: a potential therapeutic intervention for the prevention and treatment of cachexia. Clin Nutr. 2022;41(12):2843-2857.

[18] ReidyPT, Mahmassani ZS, McKenzieAI, PetrocelliJJ, Summers SA, DrummondMJ. Influence of exercise training on skeletal muscle insulin resistance in aging: spotlight on muscle ceramides. Int J Mol Sci. 2020;21(4):1514.

[19] KissN, Baguley BJ, Dalla ViaJ, FraserSF, BolamKA, DalyRM. Exercise and nutritional approaches to combat cancer-related bone and muscle loss. Curr Osteoporos Rep. 2020;18(3):291-300.

[20] MontiE, SartoF, SartoriR, et al. C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review. J Cachexia Sarcopenia Muscle. 2023;14(2):730-744.

[21] HenrotP, Blervaque L, DupinI, et al. Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models. J Cachexia Sarcopenia Muscle. 2023;14(2):745-757.

[22] DaoT, GreenAE, KimYA, et al. Sarcopenia and muscle aging: a brief overview. Endocrinol Metab. 2020;35(4):716-732.

[23] ChenR, LeiS, JiangT, She Y, ShiH. Regulation of skeletal muscle atrophy in cachexia by microRNAs and long non-coding RNAs. Front Cell Dev Biol. 2020;8:577010.

[24] ChristianCJ, BenianGM. Animal models of sarcopenia. Aging Cell. 2020;19(10):e13223.

[25] QuachTK, TaylorMF, CurriePD, Eynon N, RupareliaAA. Skeletal muscle ageing: lessons from teleosts. J Gerontol A Biol Sci Med Sci. 2024;17:glae052.

[26] Bermejo-ÁlvarezI, Pérez-BaosS, Gratal P, et al. Effects of tofacitinib on muscle remodeling in experimental rheumatoid sarcopenia. Int J Mol Sci. 2023;24(17):13181.

[27] PergandeMR, Osterbauer KJ, BuckKM, et al. Mass spectrometry-based multiomics identifies metabolic signatures of sarcopenia in rhesus monkey skeletal muscle. J Proteome Res. 2023;23(8):2845-2856.

[28] CouvertA, LacazeL, TouboulicS, et al. The Yucatan minipig model: a new preclinical model of malnutrition in obese patients with acute or chronic diseases. Clin Nutr. 2024;43(2):357-365.

[29] YingL, YaoY, LvH, et al. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway. Am J Physiol—Cell Physiol. 2022;322(5):C814-C824.

[30] GesslerL, Huraskin D, JianY, et al. The YAP1/TAZ-TEAD transcriptional network regulates gene expression at neuromuscular junctions in skeletal muscle fibers. Nucleic Acids Res. 2024;52(2):600-624.

[31] ParkS, SimKS, HeoW, KimJH. Protective effects of coumestrol on metabolic dysfunction and its estrogen receptor-mediated action in ovariectomized mice. Nutrients. 2023;15(4):954.

[32] MadamsettyVS, Mohammadinejad R, UzielieneI, et al. Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems. ACS Biomater Sci Eng. 2022;8(5):1763-1790.

[33] XieW, HeM, YuD, et al. Mouse models of sarcopenia: classification and evaluation. J Cachexia Sarcopenia Muscle. 2021;12(3):538-554.

[34] GraberTG, MarotoR, ThompsonJK, et al. Skeletal muscle transcriptome alterations related to declining physical function in older mice. J Ageing Longevity. 2023;3(2):159-178.

[35] JiS, XiongM, ChenH, et al. Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases. Signal Transduct Target Ther. 2023;8(1):116.

[36] KaurJ, FarrJN. Cellular senescence in age-related disorders. Transl Res. 2020;226:96-104.

[37] LyuW, Kousaka M, JiaH, KatoH. Effects of turmeric extract on age-related skeletal muscle atrophy in senescence-accelerated mice. Life. 2023;13(4):941.

[38] MusazziL, CariniG, BarbieriSS, et al. Phenotypic frailty assessment in SAMP8 mice: sex differences and potential role of miRNAs as peripheral biomarkers. J Gerontol: Ser A. 2023;78(11):1935-1943.

[39] WangC, ZhaoB, ZhaiJ, et al. Clinical-grade human umbilical cord-derived mesenchymal stem cells improved skeletal muscle dysfunction in age-associated sarcopenia mice. Cell Death Dis. 2023;14(5):321.

[40] CostaTJ, BarrosPR, DuarteDA, et al. Carotid dysfunction in senescent female mice is mediated by increased α(1A)-adrenoceptor activity and COX-derived vasoconstrictor prostanoids. Am J Physiol—Heart Circ Physiol. 2023;324(4):H417-H429.

[41] PolonioAM, Medrano M, Chico-SordoL, et al. Impaired telomere pathway and fertility in senescence-accelerated mice prone 8 females with reproductive senescence. Aging. 2023;15(11):4600-4624.

[42] LiuL, WangS, TianW, et al. Effect of Zbed6 single-allele knockout on the growth and development of skeletal muscle in mice. Biology. 2023;12(2):325.

[43] SoHK, KimH, LeeJ, et al. Protein arginine methyltransferase 1 ablation in motor neurons causes mitochondrial dysfunction leading to age-related motor neuron degeneration with muscle loss. Research. 2023;6:0158.

[44] KobR, Fellner C, BertschT, et al. Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat. J Cachexia Sarcopenia Muscle. 2015;6(2):181-191.

[45] KimJW, ShinSK, KwonEY. Luteolin protects against obese sarcopenia in mice with high-fat diet-induced obesity by ameliorating inflammation and protein degradation in muscles. Mol Nutr Food Res. 2023;67(6):2200729.

[46] LinL, BasuR, ChatterjeeD, Templin AT, FlakJN, JohnsonTS. Disease-associated astrocytes and microglia markers are upregulated in mice fed high fat diet. Sci Rep. 2023;13(1):12919.

[47] BennettBT, Mohamed JS, AlwaySE. The effects of calcium-β-hydroxy-β-methylbutyrate on aging-associated apoptotic signaling and muscle mass and function in unloaded but nonatrophied extensor digitorum longus muscles of aged rats. Oxid Med Cell Longevity. 2020;2020:3938672.

[48] SasakiT, YamadaE, UeharaR, Okada S, ChikudaH, YamadaM. Role of Fyn and the interleukin-6-STAT-3-autophagy axis in sarcopenia. iScience. 2023;26(10):107717.

[49] OliveiraJRS, Mohamed JS, MyersMJ, BrooksMJ, AlwaySE. Effects of hindlimb suspension and reloading on gastrocnemius and soleus muscle mass and function in geriatric mice. Exp Geront. 2019;115:19-31.

[50] BaehrLM, WestDWD, MarcotteG, et al. Age-related deficits in skeletal muscle recovery following disuse are associated with neuromuscular junction instability and ER stress, not impaired protein synthesis. Aging. 2016;8(1):127-146.

[51] IssertineM, Rosa-Caldwell ME, SungDM, BouxseinML, Rutkove SB, MortreuxM. Adaptation to full weight-bearing following disuse in rats: the impact of biological sex on musculoskeletal recovery. Physiol Rep. 2024;12(4):e15938.

[52] TyganovSA, BelovaSP, TurtikovaOV, Vikhlyantsev IM, NemirovskayaTL, ShenkmanBS. Changes in the mechanical properties of fast and slow skeletal muscle after 7 and 21 Days of restricted activity in rats. Int J Mol Sci. 2023;24(4):4141.

[53] TahimicCGT, PaulAM, SchreursAS, et al. Influence of social isolation during prolonged simulated weightlessness by hindlimb unloading. Front Physiol. 2019;10:1147.

[54] TakahashiI, Matsuzaki T, KurokiH, HosoM. Treadmill exercise suppresses histological progression of disuse atrophy in articular cartilage in rat knee joints during hindlimb suspension. Cartilage. 2023;14(4):482-491.

[55] BrownJL, Lawrence MM, AhnB, et al. Cancer cachexia in a mouse model of oxidative stress. J Cachexia Sarcopenia Muscle. 2020;11(6):1688-1704.

[56] BernardoB, Joaquim S, GarrenJ, et al. Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model. J Cachexia Sarcopenia Muscle. 2020;11(6):1813-1829.

[57] SunC, AnrakuM, KawaharaT, et al. Respiratory strength and pectoralis muscle mass as measures of sarcopenia: relation to outcomes in resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2022;163(3):779-787.e2.

[58] KlassenP, Baracos V, GramlichL, NelsonG, Mazurak V, MartinL. Computed-tomography body composition analysis complements pre-operative nutrition screening in colorectal cancer patients on an enhanced recovery after surgery pathway. Nutrients. 2020;12(12):3745.

[59] JarkovskáD, Miklovič M, Švíglerová J, et al. Effects of trandolapril on structural, contractile and electrophysiological remodeling in experimental volume overload heart failure. Front Pharmacol. 2021;12:729568.

[60] GuJ, ChenX, JinY, et al. A neonatal mouse model for pressure overload: myocardial response corresponds to severity. Front Cardiovasc Med. 2021;8:660246.

[61] KhanMS, SmegoD, IshidoyaY, et al. A canine model of chronic ischemic heart failure. Am J Physiol—Heart Circ Physiol. 2023;324(6):H751-H761.

[62] LiangX, ShangS, BaiZ, et al. Effects of renal denervation on gap junction in high-pacing-induced heart failure dogs. Anatol J Cardiol. 2024;28(9):429-436.

[63] PanY, GaoJ, GuR, et al. Effect of injection of different doses of isoproterenol on the hearts of mice. BMC Cardiovasc Disord. 2022;22(1):409.

[64] HolderER, Alibhai FJ, CaudleSL, McDermottJC, TobinSW. The importance of biological sex in cardiac cachexia. Am J Physiol—Heart Circ Physiol. 2022;323(4):H609-H627.

[65] Gortan CappellariG, Aleksova A, Dal FerroM, et al. Preserved skeletal muscle mitochondrial function, redox state, inflammation and mass in obese mice with chronic heart failure. Nutrients. 2020;12(11):3393.

[66] WangL, JiaoXF, WuC, et al. Trimetazidine attenuates dexamethasone-induced muscle atrophy via inhibiting NLRP3/GSDMD pathway-mediated pyroptosis. Cell Death Discov. 2021;7(1):251.

[67] KimDH, Elsherbini N, ZielinskiD, OskouiM. A case report of systemic intoxication following onabotulinum toxin A injections into the salivary glands in a patient with spinal muscular atrophy type 1. Pediatr Neurol. 2022;129:37-38.

[68] ChenW, ShenZ, DongW, et al. Polygonatum sibiricum polysaccharide ameliorates skeletal muscle aging via mitochondria-associated membrane-mediated calcium homeostasis regulation. Phytomedicine. 2024;129:155567.

[69] BrentMB, Lodberg A, ThomsenJS, BrüelA. Rodent model of disuse-induced bone loss by hind limb injection with botulinum toxin A. MethodsX. 2020;7:101079.

[70] AzmanKF, Zakaria R. D-galactose-induced accelerated aging model: an overview. Biogerontology. 2019;20(6):763-782.

[71] HabaY, Fujimura T, OyamaK, et al. Effect of oral branched-chain amino acids and glutamine supplementation on skeletal muscle atrophy after total gastrectomy in rat model. J Surg Res. 2019;243:281-288.

[72] OostLJ, Kustermann M, ArmaniA, BlaauwB, Romanello V. Fibroblast growth factor 21 controls mitophagy and muscle mass. J Cachexia Sarcopenia Muscle. 2019;10(3):630-642.

[73] MoralesV, González A, Cabello-VerrugioC. Upregulation of CCL5/RANTES gene expression in the diaphragm of mice with cholestatic liver disease. Adv Exp Med Biol. 2023;1408:201-218.

[74] AbrigoJ, Olguín H, TacchiF, et al. Cholic and deoxycholic acids induce mitochondrial dysfunction, impaired biogenesis and autophagic flux in skeletal muscle cells. Biol Res. 2023;56(1):30.

[75] Andres-HernandoA, Cicerchi C, GarciaGE, et al. Phosphate depletion in insulin-insensitive skeletal muscle drives AMPD activation and sarcopenia in chronic kidney disease. iScience. 2023;26(4):106355.

[76] NakaokaK, YamadaA, NodaS, Goseki-Sone M. Influence of dietary vitamin D deficiency on bone strength, body composition, and muscle in ovariectomized rats fed a high-fat diet. Nutrition. 2019;60:87-93.

[77] YamamotoS, HonmaK, FujiiM, et al. SHRSP5/Dmcr rats fed a high-fat and high-cholesterol diet develop disease-induced sarcopenia as nonalcoholic steatohepatitis progresses. Ann Anat—Anat Anz. 2023;249:152104.

[78] HahYS, LeeWK, LeeS, et al. β-Sitosterol attenuates dexamethasone-induced muscle atrophy via regulating FoxO1-dependent signaling in C2C12 cell and mice model. Nutrients. 2022;14(14):2894.

[79] GuanK, LiH, LiuD, LiuM, HeC. Identification and antioxidative mechanism of novel mitochondria-targeted MFG-E8 polypeptides in virtual screening and in vitro study. J Dairy Sci. 2023;106(3):1562-1575.

[80] JiangX, JiS, YuanF, et al. Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1-Arih2 axis. J Cachexia Sarcopenia Muscle. 2023;14(1):606-621.

[81] TumbapoS, Strudwick A, StastnaJJ, HarveySC, Bloemink MJ. Moderate dietary restriction delays the onset of age-associated sarcopenia in Caenorhabditis elegans due to reduced myosin UNC-54 degradation. Mech Ageing Dev. 2024;217:111900.

[82] DyshlyukLS, Dmitrieva AI, DrozdovaMY, MilentyevaIS, Prosekov AY. Relevance of bioassay of biologically active substances (BAS) with geroprotective properties in the model of the nematode Caenorhabditis elegans in in vivo experiments. Curr Aging Sci. 2022;15(2):121-134.

[83] DayaA, DonakaR, KarasikD. Zebrafish models of sarcopenia. Dis Models Mech. 2020;13(3):dmm042689.

[84] ChenLH, ChangSS, ChangHY, et al. Probiotic supplementation attenuates age-related sarcopenia via the gut-muscle axis in SAMP8 mice. J Cachexia Sarcopenia Muscle. 2022;13(1):515-531.

[85] van der HeydenB, van de Worp WRPH, van HelvoortA, et al. Automated CT-derived skeletal muscle mass determination in lower hind limbs of mice using a 3D U-Net deep learning network. J Appl Physiol. 2020;128(1):42-49.

[86] AhnB, SmithN, SaundersD, et al. Using MRI to measure in vivo free radical production and perfusion dynamics in a mouse model of elevated oxidative stress and neurogenic atrophy. Redox Biol. 2019;26:101308.

[87] LiuX, WuJ, TangJ, et al. Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline. J Cachexia Sarcopenia Muscle. 2023;14(5):2275-2288.

[88] KimSR, LeeEI, KimY, et al. Preclinical assessment of rodent jumping power with a novel electrical stimulation-assisted device. Sci Rep. 2023;13(1):17371.

[89] PallaAR, Ravichandran M, WangYX, et al. Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength. Science. 2021;371(6528):eabc8059.

[90] HuntLC, GracaFA, PagalaV, et al. Integrated genomic and proteomic analyses identify stimulus-dependent molecular changes associated with distinct modes of skeletal muscle atrophy. Cell Rep. 2021;37(6):109971.

[91] CheJ, XuC, WuY, et al. MiR-1290 promotes myoblast differentiation and protects against myotube atrophy via Akt/p70/FoxO3 pathway regulation. Skelet Muscle. 2021;11(1):6.

[92] KungML, YangTH, LinCC, et al. ADAR2 deficiency ameliorates non-alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1. J Cachexia Sarcopenia Muscle. 2024;15(3):949-962.

[93] DaussinFN, Boulanger E, LancelS. From mitochondria to sarcopenia: role of inflammaging and RAGE-ligand axis implication. Exp Geront. 2021;146:111247.

[94] FanM, GuX, ZhangW, et al. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles. J Cachexia Sarcopenia Muscle. 2022;13(6):2724-2739.

[95] MigliavaccaE, TaySKH, PatelHP, et al. Mitochondrial oxidative capacity and NAD(+) biosynthesis are reduced in human sarcopenia across ethnicities. Nat Commun. 2019;10(1):5808.

[96] SatoE, MoriT, MishimaE, et al. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease. Sci Rep. 2016;6:36618.

[97] XiangJ, QinL, ZhongJ, Xia N, LiangY. GLP-1RA liraglutide and semaglutide improves obesity-induced muscle atrophy via SIRT1 pathway. Diabetes Metab Syndr Obes. 2023;16:2433-2446.

[98] SpanglerEL, WaggieKS, HengemihleJ, Roberts D, HessB, IngramDK. Behavioral assessment of aging in male Fischer 344 and Brown Norway rat strains and their F1 hybrid. Neurobiol Aging. 1994;15(3):319-328.

[99] ParkSM, KimJ, BaekS, et al. Feasibility of (18)F-fluorocholine PET for evaluating skeletal muscle atrophy in a starved rat model. Diagnostics (Basel, Switzerland). 2022;12(5):1274.

[100] SathiaseelanR, AhnB, StoutMB, et al. A genetically heterogeneous rat model with divergent mitochondrial genomes. J Gerontol: Ser A. 2023;78(5):771-779.

[101] OhHJ, JinH, LeeBY. The non-saponin fraction of Korean Red Ginseng ameliorates sarcopenia by regulating immune homeostasis in 22-26-month-old C57BL/6J mice. J Ginseng Res. 2022;46(6):809-818.

[102] SerovaM, Didry-Barca B, DelouxR, et al. BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice. J Cachexia Sarcopenia Muscle. 2024;15(1):55-66.

[103] CefisM, Dargegen M, MarcangeliV, et al. MFN2 overexpression in skeletal muscles of young and old mice causes a mild hypertrophy without altering mitochondrial respiration and H₂O₂ emission. Acta Physiol (Oxf). 2024;240e14119.

[104] PajskiML, ByrdC, NandigamaN, et al. Endurance exercise preserves physical function in adult and older male C57BL/6 mice: high intensity interval training (HIIT) versus voluntary wheel running (VWR). Front Aging. 2024;5:1356954.

[105] KoJS, ChangBY, ChoiYJ, et al. Ashwagandha ethanol extract attenuates sarcopenia-related muscle atrophy in aged mice. Nutrients. 2024;16(1):157.

[106] de JongJCBC, Caspers MPM, WormsN, et al. Translatability of mouse muscle-aging for humans: the role of sex. GeroScience. 2024;46:3341-3360.

[107] ShavlakadzeT, XiongK, MishraS, et al. Age-related gene expression signatures from limb skeletal muscles and the diaphragm in mice and rats reveal common and species-specific changes. Skelet Muscle. 2023;13(1):11.

[108] WuJ, LinS, ChenW, et al. TNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis. Cell Death Discov. 2023;9(1):76.

[109] OzesB, TongL, MyersM, Moss K, RidgleyA, SahenkZ. AAV1.NT-3 gene therapy prevents age-related sarcopenia. Aging. 2023;15(5):1306-1329.

[110] HuangQ, ChenJ, LiaoS, et al. The SGLT2 inhibitor empagliflozin inhibits skeletal muscle fibrosis in naturally aging male mice through the AMPKα/MMP9/TGF-β1/Smad pathway. Biogerontology. 2024;25:567-581.

[111] OhHJ, JinH, LeeBY. Hesperidin ameliorates sarcopenia through the regulation of inflammaging and the AKT/mTOR/FoxO3a signaling pathway in 22–26-month-old mice. Cells. 2023;12(15):2015.

[112] HuangY, WuB, ShenD, Chen J, YuZ, ChenC. Ferroptosis in a sarcopenia model of senescence accelerated mouse prone 8 (SAMP8). Int J Biol Sci. 2021;17(1):151-162.

[113] MoriY, OharaM, TerasakiM, et al. Subcutaneous infusion of DNA-Aptamer raised against advanced glycation end products prevents loss of skeletal muscle mass and strength in accelerated-aging mice. Biomedicines. 2023;11(12):3112.

[114] TsumagariR, MaruoK, NakaoT, Ueda S, YamanoueM, ShiraiY. Motor dyscoordination and alteration of functional correlation between DGKγ and PKCγ in senescence-accelerated mouse prone 8 (SAMP8). Front Aging Neurosci. 2021;13:573966.

[115] AokiK, KonnoM, TokinoyaK, et al. Long-term habitual exercise and combination of β-hydroxy-β-methylbutyrate plus black ginger alter the autophagy and mitochondria related genes in SAMP8 mice. J Nutr Sci Vitaminol. 2022;68(1):39-46.

[116] ChickCN, SasakiY, KawaguchiM, Tanaka E, NiikuraT, UsukiT. LC-MS/MS quantitation of elastin crosslinker desmosines and histological analysis of skin aging characteristics in mice. Bioorg Med Chem. 2023;90:117351.

[117] FujiwaraM, Ferdousi F, IsodaH. Investigation into molecular brain aging in senescence-accelerated mouse (SAM) model employing whole transcriptomic analysis in search of potential molecular targets for therapeutic interventions. Int J Mol Sci. 2023;24(18):13867.

[118] YangS, WangL, ZengY, et al. Salidroside alleviates cognitive impairment by inhibiting ferroptosis via activation of the Nrf2/GPX4 axis in SAMP8 mice. Phytomedicine. 2023;114:154762.

[119] WangK, PuY, ChenL, et al. Optical development in the murine eye lens of accelerated senescence-prone SAMP8 and senescence-resistant SAMR1 strains. Exp Eye Res. 2024;241:109858.

[120] ChenQ, LiuR, WeiC, et al. Exogenous nucleotides ameliorate age-related decline in testosterone in male senescence-accelerated mouse Prone-8 (SAMP8) mice by modulating the local renin-angiotensin system antioxidant pathway. Nutrients. 2023;15(24):5130.

[121] GoncalvesDA, Silveira WA, ManfrediLH, et al. Insulin/IGF1 signalling mediates the effects of beta(2)-adrenergic agonist on muscle proteostasis and growth. J Cachexia Sarcopenia Muscle. 2019;10(2):455-475.

[122] SasakoT, Umehara T, SoedaK, et al. Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice. Nat Commun. 2022;13(1):5655.

[123] JiaH, LyuW, HirotaK, et al. Eggshell membrane modulates gut microbiota to prevent murine pre-cachexia through suppression of T helper cell differentiation. J Cachexia Sarcopenia Muscle. 2022;13(4):2088-2101.

[124] HosoiT, YakabeM, SasakawaH, et al. Sarcopenia phenotype and impaired muscle function in male mice with fast-twitch muscle-specific knockout of the androgen receptor. Proc Natl Acad Sci. 2023;120(4):e2218032120.

[125] SutherlandJP, ZhouA, HyppönenE. Muscle traits, sarcopenia, and sarcopenic obesity: a vitamin D mendelian randomization study. Nutrients. 2023;15(12):2703.

[126] HagiwaraK, Watanabe A, HarimotoN, et al. Liver regeneration after hepatectomy is significantly suppressed in a muscular atrophy mouse model. J Hepato-Biliary-Pancreatic Sci. 2024;31(3):152-161.

[127] TangJM, McClennan A, LiuL, et al. A protocol for simultaneous in vivo imaging of cardiac and neuroinflammation in dystrophin-deficient MDX mice using [(18)F]FEPPA PET. Int J Mol Sci. 2023;24(8):7522.

[128] WuB, DrainsM, ShahSN, et al. Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model. PLoS ONE. 2022;17(12):e0278482.

[129] LiuL, YueX, SunZ, et al. Reduction of senescent fibro-adipogenic progenitors in progeria-aged muscle by senolytics rescues the function of muscle stem cells. J Cachexia Sarcopenia Muscle. 2022;13(6):3137-3148.

[130] TeppK, Puurand M, TimohhinaN, et al. Adaptation of striated muscles to Wolframin deficiency in mice: alterations in cellular bioenergetics. Biochim Biophys Acta (BBA)—Gen Subj. 2020;1864(4):129523.

[131] ThompsonSD, Barrett KL, RugelCL, et al. Sex-specific preservation of neuromuscular function and metabolism following systemic transplantation of multipotent adult stem cells in a murine model of progeria. GeroScience. 2024;46(1):1285-1302.

[132] AlyodawiK, Vermeij WP, OmairiS, et al. Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signalling. J Cachexia Sarcopenia Muscle. 2019;10(3):662-686.

[133] ScheurenAC, D’Hulst G, KuhnGA, et al. Hallmarks of frailty and osteosarcopenia in prematurely aged PolgA(D257A/D257A) mice. J Cachexia Sarcopenia Muscle. 2020;11(4):1121-1140.

[134] PaiHL, WuPY, ChenDM, et al. Klotho null mutation involvement in adenosine A2B receptor-related skeletal muscle degeneration. Am J Pathol. 2023;193(7):950-959.

[135] TermkwancharoenC, Malakul W, PhetrungnaphaA, TunsophonS. Naringin ameliorates skeletal muscle atrophy and improves insulin resistance in high-fat-diet-induced insulin resistance in obese rats. Nutrients. 2022;14(19):4120.

[136] MankhongS, KimS, MoonS, et al. Melatonin and exercise counteract sarcopenic obesity through preservation of satellite cell function. Int J Mol Sci. 2023;24(7):6097.

[137] DantasWS, ZunicaERM, HeintzEC, et al. Mitochondrial uncoupling attenuates sarcopenic obesity by enhancing skeletal muscle mitophagy and quality control. J Cachexia Sarcopenia Muscle. 2022;13(3):1821-1836.

[138] JansenKM, DahdahN, Gama-PerezP, Schots PC, LarsenTS, Garcia-RovesPM. Impact of GLP-1 receptor agonist versus omega-3 fatty acids supplement on obesity-induced alterations of mitochondrial respiration. Front Endocrinol. 2023;14:1098391.

[139] LiangYC, ChengKP, KuoHY, et al. Calsarcin-2 may play a compensatory role in the development of obese sarcopenia. Biomedicines. 2023;11(10):2708.

[140] GeY, LiS, YaoT, et al. Promotion of healthy adipose tissue remodeling ameliorates muscle inflammation in a mouse model of sarcopenic obesity. Front Nutr. 2023;10:1065617.

[141] TianY, FuM, SuJ, et al. Gut microbiota dysbiosis and intestinal barrier impairment in diarrhea caused by cold drink and high-fat diet. Toxicology. 2024;502:153728.

[142] LeeGH, KangKK, YunHH, Jo W, OhT. Multiple time-dependent pathophysiological changes in a rabbit model of high-fat diet-induced hyperlipidemia. FEBS Open Bio. 2023;13(6):1027-1040.

[143] RenQ, SunQ, FuJ. Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease. Autophagy. 2024;20(2):221-241.

[144] LiJ, WuH, LiuY, YangL. High fat diet induced obesity model using four strains of mice: Kunming, C57BL/6, BALB/c and ICR. Exp Anim. 2020;69(3):326-335.

[145] DoulberisM, Papaefthymiou A, PolyzosSA, et al. Rodent models of obesity. Minerva Endocrinol. 2020;45(3):243-263.

[146] TakemotoR, SejimaT, HanLK, Michihara S, TakahashiR. Disuse muscle atrophy-improving effect of ninjin’ yoeito in a mouse model. Neuropeptides. 2021;90:102199.

[147] HansonAM, YoungMH, HarrisonBC, et al. Inhibiting myostatin signaling partially mitigates structural and functional adaptations to hindlimb suspension in mice. NPJ Microgravity. 2023;9(1):2.

[148] ChowdhuryP, AkelN, Jamshidi-ParsianA, et al. Degenerative tissue responses to space-like radiation doses in a rodent model of simulated microgravity. Ann Clin Lab Sci. 2016;46(2):190-197.

[149] JiaQ, QinL, NiuY, et al. Red blood cell distribution width is associated with sarcopenia risk in early-stage non-small cell lung cancer. BMC Cancer. 2024;24(1):95.

[150] IspoglouT, McCullough D, WindleA, et al. Addressing cancer anorexia-cachexia in older patients: potential therapeutic strategies and molecular pathways. Clin Nutr. 2024;43(2):552-566.

[151] PototschnigI, FeilerU, DiwokyC, et al. Interleukin-6 initiates muscle-and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia. J Cachexia Sarcopenia Muscle. 2023;14(1):93-107.

[152] NishieK, SatoS, HanaokaM. Anamorelin for cancer cachexia. Drugs Today. 2022;58(3):97-104.

[153] DossHM, KimJY, KimKS. Taurine supplementation inhibits the expression of Atrogin-1 and MURF-1, protein degradation marker genes, in skeletal muscle of C26-induced cachexia mouse model. Adv Exp Med Biol. 2022;1370:129-136.

[154] CuiH, HuD, LiuY, ZhaoJ. Identifying Acss1, Mtfp1 and Oxct1 as key regulators and promising biomarkers of sarcopenia in various models. Gene. 2024;896:148053.

[155] HildebrandtW, KeckJ, SchmichS, et al. Inflammation and wasting of skeletal muscles in Kras-p53-mutant mice with intraepithelial neoplasia and pancreatic cancer-when does cachexia start? Cells. 2022;11(10):1607.

[156] KorczakJ, MardasM, LitwiniukM, Bogdański P, Stelmach-MardasM. Androgen deprivation therapy for prostate cancer influences body composition increasing risk of sarcopenia. Nutrients. 2023;15(7):1631.

[157] ChiappalupiS, SorciG, VukasinovicA, et al. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia. J Cachexia Sarcopenia Muscle. 2020;11(4):929-946.

[158] Kim-MullerJY, SongL, LaCarubba PaulhusB, et al. GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia. Cell Rep. 2023;42(1):111947.

[159] KrysztofiakH, Wleklik M, MigajJ, et al. Cardiac cachexia: a well-known but challenging complication of heart failure. Clin Interventions Aging. 2020;15:2041-2051.

[160] HartmannJP, DahlRH, NymandS, et al. Regulation of the microvasculature during small muscle mass exercise in chronic obstructive pulmonary disease vs. chronic heart failure. Front Physiol. 2022;13:979359.

[161] WangD, SongM, ShenLF, et al. Exercise capacity is improved by levosimendan in heart failure and sarcopenia via alleviation of apoptosis of skeletal muscle. Front Physiol. 2021;12:786895.

[162] Gortan CappellariG, Aleksova A, Dal FerroM, et al. n-3 PUFA-enriched diet preserves skeletal muscle mitochondrial function and redox state and prevents muscle mass loss in mice with chronic heart failure. Nutrients. 2023;15(14):3108.

[163] SzaroszykM, KattihB, Martin-GarridoA, et al. Skeletal muscle derived musclin protects the heart during pathological overload. Nat Commun. 2022;13(1):149.

[164] BarbalhoSM, FlatoUAP, TofanoRJ, et al. Physical exercise and myokines: relationships with sarcopenia and cardiovascular complications. Int J Mol Sci. 2020;21(10):3607.

[165] OzakiY, OhashiK, OtakaN, et al. Myonectin protects against skeletal muscle dysfunction in male mice through activation of AMPK/PGC1α pathway. Nat Commun. 2023;14(1):4675.

[166] ZhaoY, LuZ, ZhangH, et al. Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression. J Adv Res. 2024;12(24):5.

[167] KuHC, ChienDK, ChaoCL, Lee SY. Left anterior descending coronary artery ligation for ischemia-reperfusion research: model improvement via technical modifications and quality control. J Visualized Exp: JoVE. 2022;16(190):e63921.

[168] VatnerDE, ZhangJ, ZhaoX, Yan L, KudejR, VatnerSF. Secreted frizzled protein 3 is a novel cardioprotective mechanism unique to the clinically relevant fourth window of ischemic preconditioning. Am J Physiol—Heart Circ Physiol. 2021;320(2):H798-H804.

[169] ZhouX, XuS, ZhangZ, et al. Gouqi-derived nanovesicles (GqDNVs) inhibited dexamethasone-induced muscle atrophy associating with AMPK/SIRT1/PGC1α signaling pathway. J Nanobiotechnol. 2024;22(1):276.

[170] MultaniI, ManjiJ, TangMJ, Herzog W, HowardJJ, GrahamHK. Sarcopenia, cerebral palsy, and botulinum toxin type A. JBJS Rev. 2019;7(8):e4.

[171] WangHH, ZhangY, QuTQ, et al. Nobiletin improves D-galactose-induced aging mice skeletal muscle atrophy by regulating protein homeostasis. Nutrients. 2023;15(8):1801.

[172] ShenS, LiaoQ, LiuJ, PanR, LeeSMY, Lin L. Myricanol rescues dexamethasone-induced muscle dysfunction via a sirtuin 1-dependent mechanism. J Cachexia Sarcopenia Muscle. 2019;10(2):429-444.

[173] LeeJ, KangM, YooJ, et al. Lactobacillus rhamnosus JY02 ameliorates sarcopenia by anti-atrophic effects in a dexamethasone-induced cellular and murine model. J Microbiol Biotechnol. 2023;33(7):915-925.

[174] MaierMC, Nankervis S, WallaceME, DevelynT, MyersMA. Dexamethasone leads to Zn(2+) accumulation and increased unbound Zn(2+) in C2C12 muscle and 3T3-L1 adipose cells. J Cell Biochem. 2023;124(3):409-420.

[175] JhuoCF, HsiehSK, ChenWY, Tzen JTC. Attenuation of skeletal muscle atrophy induced by dexamethasone in rats by teaghrelin supplementation. Molecules. 2023;28(2):688.

[176] SetoJT, Roeszler KN, MeehanLR, et al. ACTN3 genotype influences skeletal muscle mass regulation and response to dexamethasone. Sci Adv. 2021;7(27):eabg0088.

[177] LeeSY, KimJH, LeeDY, Hur SJ. Characterization of gut microbiota in mouse models of aging and sarcopenia. Microbiol Res. 2023;275:127462.

[178] QiuJ, ChengY, DengY, Ren G, WangJ. Composition of gut microbiota involved in alleviation of dexamethasone-induced muscle atrophy by whey protein. NPJ Sci Food. 2023;7(1):58.

[179] MorimotoY, KondoY, KataokaH, et al. Heat treatment inhibits skeletal muscle atrophy of glucocorticoid-induced myopathy in rats. Physiol Res. 2015;64(6):897-905.

[180] BuzattoAZ, Malkawi A, SabiEM, MujamammiAH, LiL, Abdel RahmanAM. Tissue lipidomic alterations induced by prolonged dexamethasone treatment. J Proteome Res. 2021;20(3):1558-1570.

[181] MultaniI, ManjiJ, Hastings-IsonT, KhotA, GrahamK. Botulinum toxin in the management of children with cerebral palsy. Pediatric Drugs. 2019;21(4):261-281.

[182] BrentMB, Brüel A, ThomsenJS. PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats. Bone. 2018;110:244-253.

[183] JareckiJ, Polkowska I, KazimierczakW, et al. Assessment of the impact of physical activity on the musculoskeletal system in early degenerative knee joint lesions in an animal model. Int J Mol Sci. 2023;24(4):3540.

[184] SuX, YangD, HuY, YuanY, SongL. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy. Open Life Sci. 2023;18(1):20220648.

[185] AlevK, VainA, AruM, et al. Glucocorticoid-induced changes in rat skeletal muscle biomechanical and viscoelastic properties: aspects of aging. J Manipulative Physiol Ther. 2018;41(1):19-24.

[186] WangBYH, HsiaoAWT, WongN, Chen YF, LeeCW, LeeWYW. Is dexamethasone-induced muscle atrophy an alternative model for naturally aged sarcopenia model? J Orthop Transl. 2023;39:12-20.

[187] SolishN, Carruthers J, KaufmanJ, RubioRG, GrossTM, GallagherCJ. Overview of DaxibotulinumtoxinA for injection: a novel formulation of botulinum toxin type A. Drugs. 2021;81(18):2091-2101.

[188] VerwaaijenEJ, van Hulst A, FioccoM, et al. Dexamethasone-induced sarcopenia and physical frailty in children with acute lymphoblastic leukemia: protocol for a prospective cohort study. JMIR Res Protoc. 2022;11(4):e33517.

[189] InceB, UyanikO, OltuluP, Ismayilzade M, DadaciM, SavaciN. Ethyl alcohol versus botulinum toxin A: a comparative study of the visual and histopathological outcomes in the rabbit anterior auricular muscle model. Dermatol Surg. 2020;46(12):1661-1666.

[190] CaoY, LiY, HanW, et al. Sodium butyrate ameliorates type 2 diabetes-related sarcopenia through IL-33-independent ILC2s/IL-13/STAT3 signaling pathway. J Inflamm Res. 2023;16:343-358.

[191] DengC, LuC, WangK, et al. Celecoxib ameliorates diabetic sarcopenia by inhibiting inflammation, stress response, mitochondrial dysfunction, and subsequent activation of the protein degradation systems. Front Pharmacol. 2024;15:1344276.

[192] LiuS, Mochizuki M, SuzukiY, et al. Dietary leucine supplementation restores T-cell mitochondrial respiration and regulates T-lineage differentiation in denervation-induced sarcopenic mice. J Nutr Biochem. 2024;124:109508.

[193] MankhongS, KimS, MoonS, Kwak HB, ParkDH, KangJH. Experimental models of sarcopenia: bridging molecular mechanism and therapeutic strategy. Cells. 2020;9(6):1385.

[194] DonandtT, HintzeS, KrauseS, et al. Isolation and characterization of primary DMD pig muscle cells as an in vitro model for preclinical research on duchenne muscular dystrophy. Life. 2022;12(10):1668.

[195] NakamuraS, SatoY, KobayashiT, et al. Bezafibrate attenuates immobilization-induced muscle atrophy in mice. Sci Rep. 2024;14(1):2240.

[196] LiuM, YueZ, ZhangB, Li F, LiuL, LiF. mTORC1 mediates the processes of lysine regulating satellite cells proliferation, apoptosis, and autophagy. Metabolites. 2022;12(9):788.

[197] YuM, HeX, LiuT, LiJ. lncRNA GPRC5D-AS1 as a ceRNA inhibits skeletal muscle aging by regulating miR-520d-5p. Aging. 2023;15(23):13980-13997.

[198] LimaTI, Laurila PP, WohlwendM, et al. Inhibiting de novo ceramide synthesis restores mitochondrial and protein homeostasis in muscle aging. Sci Transl Med. 2023;15(696):eade6509.

[199] KukretiH, Amuthavalli K. MicroRNA-34a causes ceramide accumulation and effects insulin signaling pathway by targeting ceramide kinase (CERK) in aging skeletal muscle. J Cell Biochem. 2020;121(5-6):3070-3089.

[200] KimA, ParkSM, KimNS, Lee H. Ginsenoside Rc, an active component of panax ginseng, alleviates oxidative stress-induced muscle atrophy via improvement of mitochondrial biogenesis. Antioxidants. 2023;12(8):1576.

[201] GuoA, HuangK, LuQ, TaoB, LiK, JiangD. TRIM16 facilitates SIRT-1-dependent regulation of antioxidant response to alleviate age-related sarcopenia. J Cachexia Sarcopenia Muscle. 2024;15(5):2056-2070.

[202] RenJ, WangJ, YaoX, et al. Investigation of the underlying mechanism of sclerosteosis expression in muscle tissue in multiple myeloma with sarcopenia. J Inflammation Res. 2023;16:563-578.

[203] MarzanAL, ChittiSV, GummadiS, Kang T, AngCS, MathivananS. Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell-derived factors. Proteomics. 2023;24:(11):e2300020.

[204] ZhaoS, ChenJ, WuL, TaoX, YaqubN, Chang J. Induced pluripotent stem cells for tissue-engineered skeletal muscles. Int J Mol Sci. 2023;24(14):11520.

[205] ZhangB, HeP, LawrenceJEG, et al. A human embryonic limb cell atlas resolved in space and time. Nature. 2023;635(8039):668-678.

[206] AllenSL, Elliott BT, CarsonBP, BreenL. Improving physiological relevance of cell culture: the possibilities, considerations, and future directions of the ex vivo coculture model. Am J Physiol—Cell Physiol. 2023;324(2):C420-C427.

[207] AlheibO, da Silva LP, KwonIK, ReisRL, Correlo VM. Preclinical research studies for treating severe muscular injuries: focus on tissue-engineered strategies. Trends Biotechnol. 2023;41(5):632-652.

[208] LerouxE, AmmarN, MoinetS, Pecot T, BoukhatmiH. Studying muscle transcriptional dynamics at single-molecule scales in Drosophila. J Visualized Exp: JoVE. 2023;8(199):e65713.

[209] RutkoveSB, ChenZZ, PandeyaS, et al. Surface electrical impedance myography detects skeletal muscle atrophy in aged wildtype zebrafish and aged gpr27 knockout zebrafish. Biomedicines. 2023;11(7):1938.

[210] ChenZL, GuoC, ZouYY, et al. Aerobic exercise enhances mitochondrial homeostasis to counteract D-galactose-induced sarcopenia in zebrafish. Exp Geront. 2023;180:112265.

[211] RupareliaAA, Salavaty A, BarlowCK, et al. The African killifish: a short-lived vertebrate model to study the biology of sarcopenia and longevity. Aging Cell. 2024;23(1):e13862.

[212] Petermann-RochaF, Balntzi V, GraySR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86-99.

[213] BossiP, DelrioP, MascheroniA, Zanetti M. The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients. 2021;13(6):1980.

[214] LanXQ, DengCJ, WangQQ, Zhao LM, JiaoBW, XiangY. The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia. Gen Comp Endocrinol. 2024;353:114513.

[215] YamanashiK, Kinugawa S, FukushimaA, et al. Branched-chain amino acid supplementation ameliorates angiotensin II-induced skeletal muscle atrophy. Life Sci. 2020;250:117593.

[216] BanksRW, Ellaway PH, ProchazkaA, ProskeU. Secondary endings of muscle spindles: structure, reflex action, role in motor control and proprioception. Exp Physiol. 2021;106(12):2339-2366.

[217] MierzejewskiB, Archacka K, GrabowskaI, FlorkowskaA, Ciemerych MA, BrzoskaE. Human and mouse skeletal muscle stem and progenitor cells in health and disease. Semin Cell Dev Biol. 2020;104:93-104.

[218] PellegrinoR, Paganelli R, Di IorioA, et al. Beyond inflammaging: the impact of immune system aging on age-related muscle decline, results from the InCHIANTI study. J Gerontol: Ser A. 2024;79(2):glad238.

[219] HuangKC, ChiangYF, HuangTC, et al. Capsaicin alleviates cisplatin-induced muscle loss and atrophy in vitro and in vivo. J Cachexia Sarcopenia Muscle. 2023;14(1):182-197.

[220] AlbaydaJ, Demonceau G, CarlierPG. Muscle imaging in myositis: MRI, US, and PET. Best Pract Res Clin Rheumatol. 2022;36(2):101765.

[221] PhamLAT, NguyenBT, HuynhDT, et al. Community-based prevalence and associated factors of sarcopenia in the Vietnamese elderly. Sci Rep. 2024;14(1):17.

[222] ChuaJR, TeeML. Association of sarcopenia with osteoporosis in patients with chronic obstructive pulmonary disease. Osteoporosis Sarcopenia. 2020;6(3):129-132.

[223] PurnamasariD, Tetrasiwi EN, KartikoGJ, AstrellaC, HusamK, LaksmiPW. Sarcopenia and chronic complications of type 2 diabetes mellitus. Rev Diabetic Stud. 2022;18(3):157-165.

[224] LenaA, AnkerMS, SpringerJ. Muscle wasting and sarcopenia in heart failure—the current state of science. Int J Mol Sci. 2020;21(18):6549.

[225] YuMD, ZhangHZ, ZhangY, et al. Relationship between chronic kidney disease and sarcopenia. Sci Rep. 2021;11(1):20523.

[226] KimYM, KimJH, BaikSJ, Chun J, YounYH, ParkH. Sarcopenia and sarcopenic obesity as novel risk factors for gastric carcinogenesis: a health checkup cohort study. Front Oncol. 2019;9:1249.

[227] KumariM, KhannaA. Prevalence of sarcopenic obesity in various comorbidities, diagnostic markers, and therapeutic approaches: a review. Ann Geriatr Med Res. 2022;26(4):296-308.

[228] SunQ, JiangX, QinR, et al. Sarcopenia among older patients with cancer: a scoping review of the literature. J Geriatr Oncol. 2022;13(7):924-934.

[229] De BrandtJ, Beijers RJ, ChilesJ, et al. Update on the etiology, assessment, and management of COPD cachexia: considerations for the clinician. Int J Chronic Obstruct Pulm Dis. 2022;17:2957-2976.

[230] KhanS, Ahmad Javid S, Ur RehmanS, AkhtarY, Amir Khan M. A systematic review of cost-effectiveness analyses examining treatments for cachexia syndrome. Nutr Cancer. 2024;76(7):584-595.

[231] MoradiK, Mohajer B, GuermaziA, et al. Cachexia in preclinical rheumatoid arthritis: longitudinal observational study of thigh magnetic resonance imaging from osteoarthritis initiative cohort. J Cachexia Sarcopenia Muscle. 2024;15(5):1823-1833.

[232] AnkerMS, Landmesser U, von HaehlingS, ButlerJ, CoatsAJS, AnkerSD. Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers. J Cachexia Sarcopenia Muscle. 2021;12(1):9-13.

[233] YedigaryanL, GattiM, MariniV, Maraldi T, SampaolesiM. Shared and divergent epigenetic mechanisms in cachexia and sarcopenia. Cells. 2022;11(15):2293.

[234] KimA, KooJH, JinX, et al. Ablation of USP21 in skeletal muscle promotes oxidative fibre phenotype, inhibiting obesity and type 2 diabetes. J Cachexia Sarcopenia Muscle. 2021;12(6):1669-1689.

[235] Ribeiro Jr.,AF, SouzaLS, AlmeidaCF, et al. Muscle satellite cells and impaired late stage regeneration in different murine models for muscular dystrophies. Sci Rep. 2019;9(1):11842.

[236] NaruseM, TrappeS, TrappeTA. Human skeletal muscle-specific atrophy with aging: a comprehensive review. J Appl Physiol. 2023;134(4):900-914.

[237] BrownJL, LeeDE, Rosa-CaldwellME, et al. Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice. J Cachexia Sarcopenia Muscle. 2018;9(5):987-1002.

[238] PaezHG, PitzerCR, AlwaySE. Age-related dysfunction in proteostasis and cellular quality control in the development of sarcopenia. Cells. 2023;12(2):249.

[239] PanL, XieW, FuX, et al. Inflammation and sarcopenia: a focus on circulating inflammatory cytokines. Exp Geront. 2021;154:111544.

[240] MizeraŁ, Halupczok-Żyła J, KolačkovK, et al. Myokines in acromegaly: an altered irisin profile. Front Endocrinol. 2021;12:728734.

[241] GungorO, UluS, HasbalNB, Anker SD, Kalantar-ZadehK. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do? J Cachexia Sarcopenia Muscle. 2021;12(6):1380-1392.

[242] MartínAI, PriegoT, Moreno-RuperezÁ, González-HedströmD, GranadoM, López-Calderón A. IGF-1 and IGFBP-3 in inflammatory cachexia. Int J Mol Sci. 2021;22(17):9469.

[243] FournierC, Karagounis LG, SaccoSM, et al. Impact of moderate dietary protein restriction on glucose homeostasis in a model of estrogen deficiency. J Nutr Biochem. 2022;102:108952.

[244] BoseP, Armstrong GAB, DrapeauP. Neuromuscular junction abnormalities in a zebrafish loss-of-function model of TDP-43. J Neurophysiol. 2019;121(1):285-297.

[245] MichelucciA, LiangC, ProtasiF, Dirksen RT. Altered Ca(2+) handling and oxidative stress underlie mitochondrial damage and skeletal muscle dysfunction in aging and disease. Metabolites. 2021;11(7):424.

[246] LiJ, WangZ, LiC, et al. Impact of exercise and aging on mitochondrial homeostasis in skeletal muscle: roles of ROS and epigenetics. Cells. 2022;11(13):2086.

[247] KubatGB, Bouhamida E, UlgerO, et al. Mitochondrial dysfunction and skeletal muscle atrophy: causes, mechanisms, and treatment strategies. Mitochondrion. 2023;72:33-58.

[248] Ramirez-SanchezI, Navarrete-Yañez V, RamirezL, et al. Restorative effects of (+)-epicatechin in a rodent model of aging induced muscle atrophy: underlying mechanisms. Food Funct. 2024;15(7):3669-3679.

[249] GhayomzadehM, Hackett D, SeyedAlinaghiS, GholamiM, Hosseini Rouzbahani N, Azevedo VoltarelliF. Combined training improves the diagnostic measures of sarcopenia and decreases the inflammation in HIV-infected individuals. J Cachexia Sarcopenia Muscle. 2022;13(2):1024-1035.

[250] ShenQ, KuangJX, MiaoCX, et al. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway. Phytomedicine. 2022;95:153858.

[251] MorawinB, Tylutka A, BielewiczF, Zembron-LacnyA. Diagnostics of inflammaging in relation to sarcopenia. Front Public Health. 2023;11:1162385.

[252] ShenY, ShiQ, NongK, et al. Exercise for sarcopenia in older people: a systematic review and network meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14(3):1199-1211.

[253] HuangH, ChenZ, ChenL, et al. Nutrition and sarcopenia: current knowledge domain and emerging trends. Front Med. 2022;9:968814.

[254] Marzuca-NassrGN, Alegría-Molina A, SanMartín-Calísto Y, et al. Muscle mass and strength gains following resistance exercise training in older adults 65–75 years and older adults above 85 years. Int J Sport Nutr Exerc Metab. 2024;34(1):11-19.

[255] EfftingPS, Thirupathi A, MüllerAP, et al. Resistance exercise training improves metabolic and inflammatory control in adipose and muscle tissues in mice fed a high-fat diet. Nutrients. 2022;14(11):2179.

[256] WijlerLA, RaatsDAE, EliasSG, et al. Specialized nutrition improves muscle function and physical activity without affecting chemotherapy efficacy in C26 tumour-bearing mice. J Cachexia Sarcopenia Muscle. 2021;12(3):796-810.

[257] ChaillouT, Montiel-Rojas D. Does the blunted stimulation of skeletal muscle protein synthesis by aging in response to mechanical load result from impaired ribosome biogenesis? Front Aging. 2023;4:1171850.

[258] XieWQ, XiaoWF, TangK, et al. Caloric restriction: implications for sarcopenia and potential mechanisms. Aging. 2020;12(23):24441-24452.

[259] YangJC, LiuM, HuangRH, et al. Loss of SELENOW aggravates muscle loss with regulation of protein synthesis and the ubiquitin-proteasome system. Sci Adv. 2024;10(38):eadj4122.

[260] SakaiH, ZhouY, MiyauchiY, et al. Increased 20S proteasome expression and the effect of bortezomib during cisplatin-induced muscle atrophy. Biol Pharm Bull. 2022;45(7):910-918.

[261] CeyhanAB, OzcanM, KimW, et al. Novel drug targets and molecular mechanisms for sarcopenia based on systems biology. Biomed Pharmacother = Biomed Pharmacother. 2024;176:116920.

[262] SenguptaA, PadhanDK, GangulyA, Sen M. Ccn6 is required for mitochondrial integrity and skeletal muscle function in zebrafish. Front Cell Dev Biol. 2021;9:627409.

[263] ElgizawyEI, AmerGS, AliEA, et al. Comparing the efficacy of concomitant treatment of resistance exercise and creatine monohydrate versus multiple individual therapies in age related sarcopenia. Sci Rep. 2024;14(1):9798.

[264] AbiriB, Hosseinpanah F, SeifiZ, AminiS, Valizadeh M. The implication of nutrition on the prevention and improvement of age-related sarcopenic obesity: a systematic review. J Nutr Health Aging. 2023;27(10):842-852.

[265] LiuC, CheungWH, LiJ, et al. Understanding the gut microbiota and sarcopenia: a systematic review. J Cachexia Sarcopenia Muscle. 2021;12(6):1393-1407.

[266] TicinesiA, Nouvenne A, CerundoloN, et al. Gut microbiota, muscle mass and function in aging: a focus on physical frailty and sarcopenia. Nutrients. 2019;11(7):1633.

[267] ShiH, LiF, ZhangF, Wei X, LiuC, DuanR. An electrical stimulation intervention protocol to prevent disuse atrophy and muscle strength decline: an experimental study in rat. J Neuroeng Rehabil. 2023;20(1):84.

[268] AkagiR, Miyokawa Y, ShiozakiD, et al. Eight-week neuromuscular electrical stimulation training produces muscle strength gains and hypertrophy, and partial muscle quality improvement in the knee extensors. J Sports Sci. 2023;41(24):2209-2228.

[269] ArnoldWD, ClarkBC. Neuromuscular junction transmission failure in aging and sarcopenia: the nexus of the neurological and muscular systems. Ageing Res Rev. 2023;89:101966.

[270] ChungH, JoY, RyuD, JeongC, ChoeSK, Lee J. Artificial-intelligence-driven discovery of prognostic biomarker for sarcopenia. J Cachexia Sarcopenia Muscle. 2021;12(6):2220-2230.

[271] UçarMK, Uçar K, UçarZ, BozkurtMR. Determination gender-based hybrid artificial intelligence of body muscle percentage by photoplethysmography signal. Comput Methods Programs Biomed. 2022;224:107010.

[272] IwasaM, TakaoM, SoufiM, et al. Artificial intelligence-based volumetric analysis of muscle atrophy and fatty degeneration in patients with hip osteoarthritis and its correlation with health-related quality of life. Int J Comput-Assisted Radiol Surg. 2023;18(1):71-78.

[273] VidalJ, Fernandez EA, WohlwendM, et al. Ryanodine receptor type 1 content decrease-induced endoplasmic reticulum stress is a hallmark of myopathies. J Cachexia Sarcopenia Muscle. 2023;14(6):2882-2897.

[274] WuM, ZhangY. Integrated bioinformatics, network pharmacology, and artificial intelligence to predict the mechanism of celastrol against muscle atrophy caused by colorectal cancer. Front Genet. 2022;13:1012932.

[275] YeZ, SarafA, RavipatiY, et al. Development and validation of an automated image-based deep learning platform for sarcopenia assessment in head and neck cancer. JAMA Network Open. 2023;6(8):e2328280.

[276] AliniM, DiwanAD, ErwinWM, Little CB, MelroseJ. An update on animal models of intervertebral disc degeneration and low back pain: exploring the potential of artificial intelligence to improve research analysis and development of prospective therapeutics. JOR Spine. 2023;6(1):e1230.

[277] ManianV, Orozco-Sandoval J, Diaz-MartinezV. An integrative network science and artificial intelligence drug repurposing approach for muscle atrophy in spaceflight microgravity. Front Cell Dev Biol. 2021;9:732370.

[278] OkamuraT, Hamaguchi M, KobayashiG, et al. A multi-omics approach to overeating and inactivity-induced muscle atrophy in db/db mice. J Cachexia Sarcopenia Muscle. 2024;15(5):2030-2045.

[279] MeijboomKE, Volpato V, Monzón-SandovalJ, et al. Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy. JCI Insight. 2021;6(13):e149446.

RIGHTS & PERMISSIONS

2024 The Author(s). MedComm - Future Medicine published by John Wiley & Sons Australia, Ltd on behalf of Sichuan International Medical Exchange & Promotion Association (SCIMEA).